药品详细
Scopolamine(东莨菪碱)
化学结构式图
中文名
东莨菪碱
英文名
Scopolamine
分子式
C17H21NO4
化学名
(1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
分子量
Average: 303.3529
Monoisotopic: 303.147058165
Monoisotopic: 303.147058165
CAS号
51-34-3
ATC分类
A04A 未知;N05C 未知;S01F 扩瞳药及睫状肌麻痹药
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Scopolamine and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic. [PubChem]
生产厂家
- Boca pharmacal inc
- Private formulations inc
封装厂家
- A. Aarons Inc.
- Adamis Laboratories
- Advanced Pharmaceutical Services Inc.
- Alcon Laboratories
- Alza Corp.
- Amend
- Apace Packaging
- Apotheca Inc.
- APP Pharmaceuticals
- Aristos Pharmaceuticals
- A-S Medication Solutions LLC
- Atlantic Biologicals Corporation
- Auriga Pharmaceuticals LLC
- Bausch & Lomb Inc.
- Baxter International Inc.
- Boca Pharmacal
- Bradley Pharmaceuticals Inc.
- Breckenridge Pharmaceuticals
- Bryant Ranch Prepack
- Burel Pharmaceuticals Inc.
- C.O. Truxton Inc.
- Carwin Associates Inc.
- Central Texas Community Health Centers
- Contract Pharm
- Cornerstone Pharmacy
- Corvit Pharmaceuticals
- Dexo LLC
- Direct Dispensing Inc.
- Dispensing Solutions
- Diversified Healthcare Services Inc.
- Excellium Pharmaceutical Inc.
- H.J. Harkins Co. Inc.
- Hawthorn Pharmaceuticals
- Hope Pharmaceuticals
- Irisys Inc.
- Kaiser Foundation Hospital
- Kenwood Labs
- Kraft Pharmaceutical Co. Inc.
- Kylemore Pharmaceuticals
- Larken Laboratories Inc.
- Liberty Pharmaceuticals
- Llorens Pharmaceutical
- Magna Pharmaceuticals
- Major Pharmaceuticals
- Mckesson Corp.
- Medi Rx Pharmaceutical Inc.
- Mikart Inc.
- Murfreesboro Pharmaceutical Nursing Supply
- Nexgen Pharma Inc.
- Novartis AG
- Nucare Pharmaceuticals Inc.
- Patient First Corp.
- PBM Pharmaceuticals Inc.
- PCA LLC
- PD-Rx Pharmaceuticals Inc.
- Pharmaceutical Utilization Management Program VA Inc.
- Pharmedix
- Physicians Total Care Inc.
- Preferred Pharmaceuticals Inc.
- Prepackage Specialists
- Provident Pharmaceuticals LLC
- Qualitest
- Rebel Distributors Corp.
- Redpharm Drug
- Remedy Repack
- River's Edge Pharmaceuticals
- Sandhills Packaging Inc.
- SJ Pharmaceuticals LLC
- Southwood Pharmaceuticals
- Sovereign Pharmaceuticals Ltd.
- Trigen Laboratories Inc.
- United Research Laboratories Inc.
- Veratex Corp.
- Vintage Pharmaceuticals Inc.
- Vision Pharma LLC
- West-Ward Pharmaceuticals
参考
Synthesis Reference | Not Available |
General Reference |
|
剂型
规格
化合物类型
Type | small molecule |
Classes | Not Available |
Substructures | Not Available |
适应症
药理
Indication | For the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness. |
Pharmacodynamics | Scopolamine is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Scopolamine has many uses including the prevention of motion sickness. It is not clear how Scopolamine prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that Scopolamine prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Scopolamine also may work directly on the vomiting center. Scopolamine must be taken before the onset of motion sickness to be effective. |
Mechanism of action | Scopolamine acts by interfering with the transmission of nerve impulses by acetylcholine in the parasympathetic nervous system (specifically the vomiting center). |
Absorption | Bioavailability is 10 - 50% |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism |
Not Available
|
Route of elimination | Less than 10% of the total dose is excreted in the urine as parent and metabolites over 108 hours. |
Half life | 4.5 hours |
Clearance | Not Available |
Toxicity | Not Available |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
||||||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
Drug | Interaction |
---|---|
Cinitapride | Anticholinergic agents like scopolamine may reduce the action of cinitapride. |
Donepezil | Possible antagonism of action |
Galantamine | Possible antagonism of action |
Haloperidol | The anticholinergic increases the risk of psychosis and tardive dyskinesia |
Tacrine | The therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Scopolamine, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents. |
Trimethobenzamide | Trimethobenzamide and Scopolamine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects. |
Triprolidine | Triprolidine and Scopolamine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects. |
Trospium | Trospium and Scopolamine, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects. |
食物相互作用
Not Available